Polyclonal antibody raised in rabbit against histone H3 containing the phosphorylated serine 10 (H3S10p), using a KLH–conjugated synthetic peptide.

ChIP results obtained with the antibody directed against H3S10p
Figure 1A: ChIP assays were performed using human HeLa cells treated with colcemid to block the cells in metaphase, the antibody against H3S10p (Cat. # 25277) and optimized PCR primer sets for qPCR. ChIP was performed on sheared chromatin from 10,000 cells. A titration of the antibody consisting of 1, 2, 5, and 10 µg per ChIP experiment was analyzed. IgG (5 µg/IP) was used as negative IP control. QPCR was performed with primers for the promoter of the active genes c-fos and RPL30. Figure 1A shows the recovery, expressed as a % of input (the relative amount of immunoprecipitated DNA compared to input DNA after qPCR analysis).
Figure 1B: ChIP was performed as described above using 2 µg of H3S10p antibody and sheared chromatin from 10,000 HeLa cells treated with colcemid (sample 1) or from 10,000 untreated cells (sample 2). QPCR was performed with primers for the promoter of the active genes c-fos and RPL30, and for the Sat2 satellite repeat region.

Determination of the titer
To determine the titer, an ELISA was performed using a serial dilution of the antibody directed against H3S10p (Cat. # 25277) and the crude serum. The antigen used was a peptide containing the histone modification of interest. By plotting the absorbance against the antibody dilution (Figure 2), the titer of the antibody was estimated to be 1:5,200.

Cross reactivity test with the antibody directed against H3S10p
A Dot Blot analysis was performed to test the cross reactivity of the antibody against H3S10p (Cat. # 25277) with peptides containing other modifications of histone H3 or the unmodified H3S10 sequence. One hundred to 0.2 pmol of the peptide containing the respective histone modification were spotted on a membrane. The antibody was used at a dilution of 1:20,000. Figure 3 shows a high specificity of the antibody for the modification of interest. Note that the antibody does not recognize the H3S10p modification if the neighboring K9 is acetylated or trimethylated.

Western blot analysis using the antibody directed against H3S10p
HeLa cells were treated with colcemid, which blocks the cell cycle in metaphase and 15 µg of histone extracts of the cells were analyzed by Western blot using the antibody against H3S10p (Cat. # 25277) diluted 1:1,000 in TBS-Tween containing 5% skimmed milk. The position of the protein of interest is indicated on the right; the marker (in kDa) is shown on the left.

Immunofluorescence using the antibody directed against H3S10p
Human osteosarcoma (U2OS) cells were stained with the antibody against H3S10p (Cat. # 25277) and with DAPI. Cells were fixed with 3.7% formaldehyde in PBS for 20 minutes at RT, followed by a 20’ permeabilization with 0.5% Triton X-100 in PBS and blocked PBS/TX-100 containing 5% normal goat serum. Figure 5A: cells were immunofluorescently labeled with the H3S10p antibody (left), diluted 1:2,000 in blocking buffer followed by an anti-rabbit antibody conjugated to Alexa568 or with DAPI (right), which specifically labels DNA. Figure 5B, C and D: staining of the cells with the H3S10p antibody after incubation of the antibody with 2 µM blocking peptide containing the unmodified H3S10 sequence, the phosphorylated H3S10 and the phosphorylated H3T11, respectively.

50 µg/48 µl

PBS containing 0.05% azide and 0.05% ProClin 300.

Human

Affinity purified

synthetic peptide

Aqueous buffer solution

Store at –80°C for up to 2 years. Centrifuge after first thaw to maximize product recovery. Aliquot to avoid repeated freeze/thaw cycles. Aliquots may be stored at –20°C for at least one month.

ChIP (2 µg/IP)
ELISA (1:100)
DB (1:20,000)
WB (1:1000)
IF (1:2000)

The optimal antibody amount per IP should be determined by the end–user. We recommend testing 1–5 µg per IP

Avoid freeze/thaw cycles

Antibodies

Antibody